# Allen Cell Nuclei: Systematic SPHARM Benchmark — lmax 1–8

## Overview

Bayesian-optimized classification results for raw SPHARM coefficients and
rotation-invariant SPHARM features (power spectrum + bispectrum) at lmax=1–8,
using the lmax=16 CSV truncated at each lmax value.

**Classifier**: LinearSVC (liblinear)
**Dataset**: Non-rotated nuclei only (`nuclei/`)
**Optimization**: BayesSearchCV, n_iter=20, 5-fold stratified CV
**Evaluation**: 3 seeds, balanced accuracy + geometric mean
**Input**: `spherical_harmonics_lmax_16.csv` (filtered to L≤lmax, M≤lmax per run)

---

## Results

### Raw SPHARM (orientation-dependent coefficients)

| lmax | # Features | Balanced Accuracy | Geo. Mean | Best C | Best PCA |
|------|------------|-------------------|-----------|--------|----------|
| 1 | 8 | 0.423 ± 0.001 | 0.352 ± 0.009 | 0.10 | 4 |
| 2 | 18 | 0.495 ± 0.006 | 0.460 ± 0.007 | 1.08 | 18 |
| 3 | 32 | 0.547 ± 0.001 | 0.521 ± 0.001 | 13.3 | 22 |
| 4 | 50 | **0.601 ± 0.006** | **0.587 ± 0.006** | 0.11 | 30 |
| 5 | 72 | 0.597 ± 0.003 | 0.584 ± 0.004 | 0.39 | 57 |
| 6 | 98 | 0.604 ± 0.002 | 0.587 ± 0.002 | 0.10 | 57 |
| 7 | 128 | 0.609 ± 0.005 | 0.594 ± 0.005 | 0.23 | 115 |
| 8 | 162 | 0.606 ± 0.006 | 0.588 ± 0.007 | 997 | 78 |

### SPHARM Invariants (rotation-invariant power spectrum + bispectrum)

| lmax | # Features | Balanced Accuracy | Geo. Mean | Best C | Best PCA |
|------|------------|-------------------|-----------|--------|----------|
| 1 | 6 | 0.444 ± 0.001 | 0.306 ± 0.017 | 13.3 | 5 |
| 2 | 14 | 0.589 ± 0.006 | 0.578 ± 0.006 | 1000 | 9 |
| 3 | 27 | 0.628 ± 0.004 | 0.618 ± 0.004 | 739 | 21 |
| 4 | 47 | 0.686 ± 0.002 | 0.672 ± 0.003 | 45.4 | 42 |
| 5 | 75 | 0.726 ± 0.004 | 0.713 ± 0.006 | 739 | 57 |
| 6 | 113 | 0.740 ± 0.002 | 0.726 ± 0.001 | 11.0 | 60 |
| 7 | 162 | 0.764 ± 0.001 | 0.753 ± 0.002 | 13.3 | 110 |
| 8 | 224 | **0.771 ± 0.013** | **0.761 ± 0.015** | 739 | 170 |

---

## Interpretation

### SPHARM Inv monotonically improves across all lmax; approaching saturation at lmax=8

SPHARM Inv increases at every lmax step:

| Step | Δ Bal. Acc |
|------|-----------|
| lmax 1→2 | +14.5 pp |
| lmax 2→3 | +3.9 pp |
| lmax 3→4 | +5.8 pp |
| lmax 4→5 | +4.0 pp |
| lmax 5→6 | +1.4 pp |
| lmax 6→7 | +2.4 pp |
| lmax 7→8 | +0.7 pp |

The incremental gains diminish from lmax=5 onward (+1.4, +2.4, +0.7 pp), suggesting the
performance curve is flattening. The lmax=7→8 gain of +0.7 pp is within the noise level
of the lmax=8 estimate (±1.3 pp std dev), so lmax=8 may be near saturation.

### Raw SPHARM plateaus around 0.600 from lmax=4 onward

Raw SPHARM peaks at lmax=4 (0.601) and fluctuates between 0.597–0.609 at lmax=4–8,
showing no systematic gain from higher frequency bands. The C values span 0.10–997
with no clear pattern, and the very low values (0.10–0.39) at most lmax confirm that
the orientation-dependent coefficients are highly collinear: different rotations of the
same shape produce very different coefficient vectors that a linear classifier must
regularise heavily to handle. Adding more bands just introduces more correlated noise.
This confirms raw SPHARM coefficients are a poor choice for linear classification unless
the dataset is perfectly rotation-normalised.

### SPHARM Inv consistently and increasingly outperforms raw SPHARM

At every lmax, SPHARM Inv > raw SPHARM. The gap widens with lmax:

| lmax | SPHARM Inv | Raw SPHARM | Gap |
|------|------------|------------|-----|
| 1 | 0.444 | 0.423 | +2.1 pp |
| 4 | 0.686 | 0.601 | +8.5 pp |
| 5 | 0.726 | 0.597 | +12.9 pp |
| 7 | 0.764 | 0.609 | +15.5 pp |
| 8 | 0.771 | 0.606 | +16.5 pp |

### SPHARM Inv at lmax=8 matches CellProfiler (full)

At lmax=8, SPHARM Inv reaches 0.771 ± 0.013 — statistically identical to CellProfiler
(full 22 features: 0.769 ± 0.003). This is a notable crossover: with enough frequency
bands, the power spectrum + bispectrum of the nuclear shape recovers the same
discriminative signal as standard image analysis descriptors (volume, surface area,
axis lengths, bounding box, solidity).

However, SPHARM Inv at lmax=8 still sits below Minkowski-based feature sets:
- Eigenvalues only (18 features): 0.791 — already better than SPHARM Inv lmax=8 (224 features)
- SO3 Degree 2 (39 features): 0.783
- SO3 Degree 2 + Eigenvalues (57 features): 0.817
- Minkowski (tensors+eigen+beta, 86 features): 0.818

The SPHARM power spectrum + bispectrum is a signal derived from the surface mesh
expansion, whereas the Minkowski tensor eigenvalues encode shape anisotropy more
directly and compactly. Even 8 bands (224 SPHARM features) do not recover the
information contained in 18 eigenvalues.

---

## Runtime

- lmax=1–5: ~6 min (10 feature sets, n_iter=20, 5-fold CV, 3 seeds, LinearSVC, n_jobs=5, Apple Silicon)
- lmax=6–8: ~14 min (6 feature sets, same settings)

---

## Configuration

```bash
# lmax=1–5
python benchmarks/invariants_classification.py \
    --input ../Minkowski_classifier/data/allen_cell/mitotic_cells_annotated/nuclei/minkowski_tensors_with_eigen_vals.csv \
    --spharm-input ../Minkowski_classifier/data/allen_cell/mitotic_cells_annotated/nuclei/spherical_harmonics_lmax_16.csv \
    --spharm-lmax 1 2 3 4 5 \
    --output benchmarks/results/allen_cell_nuclei_spharm_systematic \
    --include "SPHARM" \
    --optimize \
    --n_iter 20 \
    --linear-only \
    --seeds 3 \
    --n_jobs 5

# lmax=6–8
python benchmarks/invariants_classification.py \
    --input ../Minkowski_classifier/data/allen_cell/mitotic_cells_annotated/nuclei/minkowski_tensors_with_eigen_vals.csv \
    --spharm-input ../Minkowski_classifier/data/allen_cell/mitotic_cells_annotated/nuclei/spherical_harmonics_lmax_16.csv \
    --spharm-lmax 6 7 8 \
    --output benchmarks/results/allen_cell_nuclei_spharm_systematic_678 \
    --include "SPHARM" \
    --optimize \
    --n_iter 20 \
    --linear-only \
    --seeds 3 \
    --n_jobs 5
```
